C57BL/6N-Tmprss6tm1b(EUCOMM)Wtsi/Ics

Status

Available to order

EMMA IDEM:16228
Citation informationRRID:IMSR_EM:16228 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameC57BL/6N-Tmprss6tm1b(EUCOMM)Wtsi/Ics
Alternative nameTmprss6tm1b(EUCOMM)Wtsi/Ics
Strain typeTargeted Mutant Strains : Knock-out
Allele/Transgene symbolTmprss6tm1b(EUCOMM)Wtsi
Gene/Transgene symbolTmprss6

Information from provider

Provider ICS, Institut Clinique de la Souris
Provider affiliationICS, Institut Clinique de la Souris
Genetic informationThe cre-mediated excision of the parental Tmprss6tm1a(EUCOMM)Wtsi allele resulted in the removal of the promoter-driven neomycin selection cassette and critical exon(s) leaving behind the inserted lacZ reporter sequence.
Phenotypic informationHomozygous:
N/A

Heterozygous:
N/A
Breeding history100% C57BL/6N (C57BL/6NCrl 74,61% C57BL/6NTac 25,39%)
ReferencesNone available
Homozygous fertilenot known
Homozygous viablenot known
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreICS, Institut Clinique de la Souris, Illkirch-Graffenstaden, France

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching

IMPC phenotypes (allele matching)
  • increased circulating calcium level / IMPC
  • decreased hematocrit / IMPC
  • abnormal coat/ hair morphology / IMPC
  • decreased locomotor activity / IMPC
  • decreased exploration in new environment / IMPC
  • abnormal coat appearance / IMPC
  • abnormal skin morphology / IMPC
  • abnormal coat/hair pigmentation / IMPC
  • decreased mean corpuscular volume / IMPC
  • short tibia / IMPC
  • increased heart weight / IMPC
  • decreased hemoglobin content / IMPC
  • immune system phenotype / IMPC
  • decreased mean corpuscular hemoglobin / IMPC
  • decreased mean corpuscular hemoglobin concentration / IMPC
  • decreased NK cell number / IMPC
  • decreased CD8-positive, alpha-beta T cell number / IMPC
  • decreased prepulse inhibition / IMPC
  • increased effector memory CD8-positive, alpha-beta T cell number / IMPC
  • increased fasting circulating glucose level / IMPC
  • increased CD11b-high dendritic cell number / IMPC
  • increased Ly6C-positive mature NK cell number / IMPC
IMPC phenotypes (gene matching)
  • short tibia / IMPC
  • decreased prepulse inhibition / IMPC
  • decreased mean corpuscular hemoglobin concentration / IMPC
  • abnormal coat/ hair morphology / IMPC
  • abnormal coat/hair pigmentation / IMPC
  • decreased exploration in new environment / IMPC
  • abnormal skin morphology / IMPC
  • decreased locomotor activity / IMPC
  • increased heart weight / IMPC
  • increased fasting circulating glucose level / IMPC
  • abnormal coat appearance / IMPC
  • increased Ly6C-positive mature NK cell number / IMPC
  • decreased NK cell number / IMPC
  • increased circulating calcium level / IMPC
  • decreased mean corpuscular hemoglobin / IMPC
  • increased CD11b-high dendritic cell number / IMPC
  • decreased mean corpuscular volume / IMPC
  • decreased hemoglobin content / IMPC
  • increased effector memory CD8-positive, alpha-beta T cell number / IMPC
  • immune system phenotype / IMPC
  • decreased CD8-positive, alpha-beta T cell number / IMPC
  • decreased hematocrit / IMPC
MGI phenotypes (gene matching)
  • decreased hematocrit / MGI
  • extramedullary hematopoiesis / MGI
  • abnormal hair follicle morphology / MGI
  • alopecia / MGI
  • sparse hair / MGI
  • focal hair loss / MGI
  • decreased body size / MGI
  • anemia / MGI
  • abnormal intestinal mineral absorption / MGI
  • postnatal growth retardation / MGI
  • abnormal iron level / MGI
  • reduced female fertility / MGI
  • female infertility / MGI
  • abnormal erythrocyte morphology / MGI
  • decreased mean corpuscular volume / MGI
  • reticulocytosis / MGI
  • anisopoikilocytosis / MGI
  • microcytic anemia / MGI
  • microcytosis / MGI
  • decreased hemoglobin content / MGI
  • decreased erythrocyte cell number / MGI
  • abnormal ovary development / MGI
  • pallor / MGI
  • maternal effect / MGI
  • decreased circulating iron level / MGI
  • increased spleen weight / MGI
  • hematopoietic system phenotype / MGI
  • decreased mean corpuscular hemoglobin / MGI
  • abnormal iron homeostasis / MGI
  • decreased mean corpuscular hemoglobin concentration / MGI
  • decreased liver iron level / MGI
  • decreased spleen iron level / MGI
  • progressive hair loss / MGI
  • increased red blood cell distribution width / MGI
  • abnormal hair follicle infundibulum morphology / MGI
  • thin hair follicle outer root sheath / MGI
  • mortality/aging / MGI
  • postnatal lethality, incomplete penetrance / MGI
  • increased circulating unsaturated transferrin level / MGI
  • decreased pancreas iron level / MGI
  • decreased heart iron level / MGI

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).